Table 3. Chemical and Metabolic Stability of Aryl N-[ω-(6-Fluoroindol-1-yl)alkyl]carbamates and Aryl 4-[2-(6-Fluoroindol-1-yl)ethyl]piperidine-1-carboxylates.
stability
(%)a |
|||||
---|---|---|---|---|---|
comp. | R | porcine liver S9 fractions | porcine blood plasma | porcine albumin solution | PBS buffer (pH 7.4) |
14 | 4-phenyl | 76 ± 2 | 83 ± 9n = 8 | 93 ± 6n = 6 | >95 |
26 | 4-fluorophenyl | 69 ± 4 | 59 ± 13n = 6 | 91 ± 6n = 5 | >95 |
27 | 3-fluorophenyl | 62 ± 5 | 10 ± 3 | 76 ± 4 | >95 |
28 | 2-fluorophenyl | 76 ± 2 | 19 ± 6 | 69 ± 5 | 91 ± 3 |
29 | 4-cyanophenyl | n.t. | n.t. | n.t. | 12 ±3 |
30 | 3-cyanophenyl | 49 ± 4 | < 5 | <5 | 72 ± 3 |
31 | 2-cyanophenyl | n.t. | n.t. | n.t. | 3 ± 2 |
33 | 4-carboxyphenyl | 59 ± 6 | 37 ± 2 | 90 ± 9 | >95 |
35 | 3-carboxyphenyl | 74 ± 2 | 78 ± 1 | 93 ± 3 | >95 |
37 | 2-carboxyphenyl | 77 ± 3 | 28 ± 4 | 74 ± 2 | 73 ± 6 |
39 | 4-(carboxymethyl)phenyl | 85 ± 3 | 88 ± 4 | >95 | >95 |
41 | 3-(carboxymethyl)phenyl | 73 ± 2 | 83 ± 5 | >95 | >95 |
43 | 2-(carboxymethyl)phenyl | 82 ± 5 | 89 ± 1 | 89 ± 3 | >95 |
44 | pyridin-3-yl | 53 ± 7 | <5 | 27 ± 3 | 60 ± 2 |
45 | 2-methylpyridin-3-yl | 65 ± 9 | 23 ± 6 | 70 ± 8 | 75 ± 4 |
46 | 4-methylpyridin-3-yl | 56 ± 8 | 8 ± 2 | 68 ± 6 | 74 ± 4 |
47 | 5-methylpyridin-3-yl | 57 ± 5 | <5 | 37 ± 4 | 72 ± 4 |
48 | 6-methylpyridin-3-yl | 51 ± 9 | <5 | 62 ± 4 | 82 ± 6 |
49 | indol-4-yl | 78 ± 4 | 80 ± 3 | 81 ± 6 | >95 |
54 | 4-carboxy | 66 ± 9 | 94 ± 3 | 93 ± 8 | >95 |
56 | 3-carboxy | 72 ± 7 | >95 | 94 ± 3 | >95 |
58 | 2-carboxy | 72 ± 6 | >95 | 89 ± 6 | >95 |
URB597 (1) | 80 ± 4 | 77 ± 6 | 95 ± 7 | >95 | |
ABX-1431 (2) | 81 ± 3 | 95 ± 2 | 87 ± 6 | 90 ± 5 | |
physostigmine | 57 ± 4 | >95 | >95 | >95 |
Percent of parent remaining after incubation in porcine liver homogenate, porcine plasma, or porcine albumin solution for 30 min or PBS buffer (pH 7.4) for 60 min; values are means ± standard deviations of independent determinations (n = 3, unless otherwise stated); n.t., not tested.